International Summit on Innovative Research and Development of Biological Medicine and Industrial De

Shenzhen bio pharmaceutical industry has the rapid development of economic basis and policy advantages, but still faces many challenges, especially the source of innovation in a new class of biological drug development and transformation.
How to fit the international strategic planning of Shenzhen Dapeng international Bio Valley, leading Shenzhen bio pharmaceutical industry into the international leading ranks, creation and the introduction of a number of major drug discovery in 13th Five-Year in accordance with national planning of biological drug innovation?
How to set up synchronization or the introduction of bio pharmaceutical industry from incubation R & D, pilot production, product identification, pre clinical research, clinical application documents, to the service platform for the various important clinical trials until the new drug approval in the industry chain, to achieve international Bio Valley within the pharmaceutical industry chain to complete?
How to social capital in the early stage of development, the introduction of external resources, broaden the pipeline, choose the right investment mode, the construction of financial "incubation, production and research and development of capital" from research to the healthy development of enterprises?
In Shenzhen Rozman International Institute for translational medicine sponsored international conference on drug development and conversion of 2016, very honored to be invited to the senior executives of top international scientists, academicians and leading international biopharmaceutical company more than 10 U.S. anti tumor and anti infection medicine into the field; expert investment in the field of bio pharmaceutical industry experts, senior academician Chinese drug R & D industry veteran observers, drug evaluation regulations, experts and more than 10 Chinese medicine for transforming the field of come to share and discuss how to open and complete from the foundation to the development of innovative drug clinical industrial chain together with us.

Conference theme:
"From the foundation to the clinical - complete innovative drug development industry chain"
(a) the present situation and future of anti infection vaccine
(two) the early results of drug development
(three) the view of tumor biological therapy
(four) the industry chain of new drug research and development"

Assembly report time:
November 11th 9:00--18:00 Shenzhen Wuzhou Hotel Building A lobby Congress register office
November 12th 8:00--9:00 Shenzhen Wuzhou Hotel Building A lobby Congress register office
Speaker of the conference:
American Cancer Medicine and the Academy of microbiology / leading scientists
Chinese Journal of oncology and microbiology / leading scientists
International biological pharmaceutical company (GileadSciences, Pfizeretc) executives
New drug research and development industry veteran observers
Expert on new drug review regulations
Experts in the field of bio pharmaceutical industry investment